🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jennifer L. Caswell‐Jin

Cancer Prevention Institute of California

ORCID: 0000-0002-5711-8355

Also affiliated with Stanford Medicine, Stanford Cancer Institute, Stanford University

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

2.3Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)

Nature Communications(2020)10.1038/s41467-020-19494-2

Top 9%

2.3DataRank

Top 9%66 citations

Jennifer L. Caswell‐Jin, Katherine McNamara, Jason J. Zoeller, Gregory R. Bean, Robert Dichmann +20 more

Papers

Driven by 11 papers — median percentile 91. Top paper: “Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)”.

Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)

Nature Communications(2020)10.1038/s41467-020-19494-2

Top 9%

2.3DataRank

Top 9%66 citations

Jennifer L. Caswell‐Jin, Katherine McNamara, Jason J. Zoeller, Gregory R. Bean, Robert Dichmann +20 more

Collaborative Modeling to Compare Different Breast Cancer Screening Strategies

JAMA(2024)10.1001/jama.2023.24766

N/A

0.598DataRank · unranked

53 citations

Christina Chapman, Jinani Jayasekera, Kathryn P. Lowry, Brandy M. Heckman‐Stoddard, John M. Hampton +30 more

Performance of the IBIS/Tyrer-Cuzick (TC) Model by race/ethnicity in the Women’s Health Initiative.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.1503

N/A

0DataRank · unranked

4 citations

Elisha Hughes, Ryan Bernhisel, Braden Probst, Jerry S. Lanchbury, Susanne Wagner +8 more

Performance of the IBIS/Tyrer‐Cuzick model of breast cancer risk by race and ethnicity in the Women's Health Initiative

Cancer(2021)10.1002/cncr.33767

N/A

0DataRank · unranked

55 citations

Elisha Hughes, Timothy Simmons, Ryan Bernhisel, Braden Probst, Stephanie Meek +13 more

Contributions of screening, early-stage treatment, and metastatic treatment to breast cancer mortality reduction by molecular subtype in U.S. women, 2000-2017.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.1008

N/A

0DataRank · unranked

9 citations

Liyang Sun, Diego A. Muñoz, Ying Lü, Yisheng Li, Hui Huang +14 more

Association of germline genetic testing results with chemotherapy regimens received by women with early-stage breast cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.10518

N/A

0DataRank · unranked

1 citations

Paul Abrahamse, Jennifer L. Caswell‐Jin, Ann S. Hamilton, Timothy P. Hofer, Kevin C. Ward +2 more

Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020

JAMA Oncology(2024)10.1001/jamaoncol.2024.5381

N/A

0DataRank · unranked

73 citations

Eric J. Feuer, Jeanne S. Mandelblatt, Rafael Meza, Theodore R. Holford, Jihyoun Jeon +18 more

The population-level effects of omitting chemotherapy guided by a 21-gene expression assay in node-positive breast cancer: a simulation modeling study

BMC Cancer(2024)10.1186/s12885-024-12719-3

N/A

0DataRank · unranked

3 citations

Jennifer L. Caswell‐Jin, Oliver W.A. Wilson, Clyde B. Schechter, Dalya Kamil, Allison W. Kurian +2 more

Development and Validation of a Simulation Model–Based Tool to Support Individualized Physical Activity Discussions and Prescriptions for Breast Cancer Survivors

JCO Clinical Cancer Informatics(2025)10.1200/cci-25-00151

N/A

0DataRank · unranked

6 citations

Oliver W.A. Wilson, Clyde B. Schechter, Jennifer L. Caswell‐Jin, Kaitlyn M. Wojcik, Nicolien T. van Ravesteyn +11 more

Mathematical Modeling to Address Questions in Breast Cancer Screening: An Overview of the Breast Cancer Models of the Cancer Intervention and Surveillance Modeling Network

Journal of Breast Imaging(2025)10.1093/jbi/wbaf003

N/A

0DataRank · unranked

3 citations

Jennifer L. Caswell‐Jin, Harry J. de Koning, Hui Huang, Xuelin Huang, Sandra J. Lee +10 more

Prevalence of Pathogenic Variants in Cancer Susceptibility Genes Among Women With Postmenopausal Breast Cancer

JAMA(2020)10.1001/jama.2020.0229

N/A

0DataRank · unranked

39 citations

Ryan Bernhisel, Katie Larson, Jennifer L. Caswell‐Jin, Aladdin H. Shadyab, Heather M. Ochs‐Balcom +2 more